Hepatitis C Information - Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral ...

Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral ...
PR Newswire (press release), NY - Jan 18, 2006- Patient Enrollment and Dosing in Initial Phase I Trial Now Scheduled for Completion in February - - Preliminary Phase I Safety Data to Be Presented at 'Viral ...

Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral ...
Biotech Intelligence (press release), France - Jan 18, 2006TUSTIN, Calif., Jan. 18 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), a biopharmaceutical company with ...

Peregrine Announces Acceleration of Its Tarvacin Anti-Viral ...
PharmaLive.com (press release), PA - Jan 18, 2006TUSTIN, Calif., Jan. 18, 2006 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio ...

Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in ...
RxPG NEWS, CA - Jan 18, 2006By Peregrine Pharmaceuticals, Inc., Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio ...